Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer
3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer
3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer
Submitted by
admin
on August 24, 2023 - 9:50pm
Source:
Motley Fool
News Tags:
Novo Nordisk
Ozempic
diabetes
weight loss
liver disease
addiction
cardiovascular disease
Headline:
3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer
snippet:
The active ingredient in Ozempic could be useful for quite a few conditions.
Cardiovascular disease, certain chronic liver diseases, and addiction are just a few.
Clinical trials need to impress regulators before there's a chance of making a dime.
Do Not Allow Advertisers to Use My Personal information